StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report released on Tuesday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens upped their target price on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
Read Our Latest Stock Report on Veradigm
Veradigm Trading Down 1.4 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Dividend Payout Ratio Calculator
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Want to Profit on the Downtrend? Downtrends, Explained.
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
